01
Summary

After analyzing over 40 probiotics across 69 trials, we’ve identified the most promising probiotics for managing gas and flatulence in IBS. Our dataset (below) is ordered based on an automated scoring system, which we further refined using additional criteria (below) to select our top choices. Here are the results of our findings.

Our Top Choice(s)

  1. Unique IS-2
    Bacillus coagulans Unique IS-2 earned the top spot in our rankings for gas and flatulence relief in IBS due to its effectiveness and high-quality evidence in two key studies:
  • Study 1 (Children with IBS): Over an 8-week period, children who took Bacillus coagulans Unique IS-2 saw a remarkable 76.5% improvement in gas-related symptoms, with their mean score dropping from 3.4 to 0.8. The effect size was a strong 1.21. (1)
  • Study 2 (Adults with IBS): Similarly, adults experienced a 62.5% reduction in gas symptoms, with their scores decreasing from 3.2 to 1.2. The effect size here was even larger at 1.72. Both studies found these changes to be statistically significant (p < 0.0001), reinforcing the positive impact of this probiotic on gas relief. (2)

Our Criteria

The probiotics in our full database (below) are automatically ranked based on their 1) effect size for gas relief, followed by 2) effect size for overall IBS symptoms (‘Global IBS Symptoms’), and finally by 3) the quality of evidence from the studies. 

For this summary, we selected our top choices based on these rankings, along with the following additional criteria:

  • Evidence Quality Score: We only included probiotics backed by studies with an evidence quality score of 75% or higher, specifically in the context of gas/flatulence.
  • Effect Size: Only probiotics that demonstrated a moderate to high effect size (>0.5) for gas relief made the cut.
  • Clear Dosing Information: Only probiotics with clear and reliable dosing data were included.
  • Commercial Availability: Probiotics needed to be commercially available to consumers.

No Direct Comparisons 

It’s important to note that there are no direct comparisons between the probiotics in our database across identical study methods, so we can’t definitively rank one probiotic as superior to another. Bacillus coagulans Unique IS-2 shows promise for gas relief in IBS, but as with all probiotic supplements, always consult your healthcare provider before starting.

Our Ranking Probiotic Gas Relief Effect Size* Global IBS Symptoms Effect Size Evidence Quality Number of Studies Number of Participants
1 IS-2 1.43 1.45 86% 2 249

*Population values represent the per protocol population size from studies specifically assessing a gas-related parameter.

*Effect sizes are reported as the weighted mean effect size across studies.

References

  1. Sudha MR, Jayanthi N, Aasin M, et al. Efficacy of Bacillus coagulans Unique IS2 in the treatment of irritable bowel syndrome in children: a double-blind, randomised placebo-controlled study. Benef Microbes. 2018;9(4):563-572. doi:10.3920/BM2017.0129.
  2. Madempudi RS, Ahire JJ, Neelamraju J, et al. Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults. Sci Rep. 2019;9:12210. doi:10.1038/s41598-019-48554-x.
Read More…

After analyzing over 40 probiotics across 69 trials, we’ve identified the most promising probiotics for managing gas and flatulence in IBS. Our dataset (below) is ordered based on an automated scoring system, which we further refined using additional criteria (below) to select our top choices. Here are the results of our findings.

Our Top Choice(s)

  1. Unique IS-2
    Bacillus coagulans Unique IS-2 earned the top spot in our rankings for gas and flatulence relief in IBS due to its effectiveness and high-quality evidence in two key studies:
  • Study 1 (Children with IBS): Over an 8-week period, children who took Bacillus coagulans Unique IS-2 saw a remarkable 76.5% improvement in gas-related symptoms, with their mean score dropping from 3.4 to 0.8. The effect size was a strong 1.21. (1)
  • Study 2 (Adults with IBS): Similarly, adults experienced a 62.5% reduction in gas symptoms, with their scores decreasing from 3.2 to 1.2. The effect size here was even larger at 1.72. Both studies found these changes to be statistically significant (p < 0.0001), reinforcing the positive impact of this probiotic on gas relief. (2)

Our Criteria

The probiotics in our full database (below) are automatically ranked based on their 1) effect size for gas relief, followed by 2) effect size for overall IBS symptoms (‘Global IBS Symptoms’), and finally by 3) the quality of evidence from the studies. 

For this summary, we selected our top choices based on these rankings, along with the following additional criteria:

  • Evidence Quality Score: We only included probiotics backed by studies with an evidence quality score of 75% or higher, specifically in the context of gas/flatulence.
  • Effect Size: Only probiotics that demonstrated a moderate to high effect size (>0.5) for gas relief made the cut.
  • Clear Dosing Information: Only probiotics with clear and reliable dosing data were included.
  • Commercial Availability: Probiotics needed to be commercially available to consumers.

No Direct Comparisons 

It’s important to note that there are no direct comparisons between the probiotics in our database across identical study methods, so we can’t definitively rank one probiotic as superior to another. Bacillus coagulans Unique IS-2 shows promise for gas relief in IBS, but as with all probiotic supplements, always consult your healthcare provider before starting.

Our Ranking Probiotic Gas Relief Effect Size* Global IBS Symptoms Effect Size Evidence Quality Number of Studies Number of Participants
1 IS-2 1.43 1.45 86% 2 249

*Population values represent the per protocol population size from studies specifically assessing a gas-related parameter.

*Effect sizes are reported as the weighted mean effect size across studies.

References

  1. Sudha MR, Jayanthi N, Aasin M, et al. Efficacy of Bacillus coagulans Unique IS2 in the treatment of irritable bowel syndrome in children: a double-blind, randomised placebo-controlled study. Benef Microbes. 2018;9(4):563-572. doi:10.3920/BM2017.0129.
  2. Madempudi RS, Ahire JJ, Neelamraju J, et al. Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults. Sci Rep. 2019;9:12210. doi:10.1038/s41598-019-48554-x.
Read More…

After analyzing over 40 probiotics across 69 trials, we’ve identified the most promising probiotics for managing gas and flatulence in IBS. Our dataset (below) is ordered based on an automated scoring system, which we further refined using additional criteria (below) to select our top choices. Here are the results of our findings.

Our Top Choice(s)

  1. Unique IS-2
    Bacillus coagulans Unique IS-2 earned the top spot in our rankings for gas and flatulence relief in IBS due to its effectiveness and high-quality evidence in two key studies:
  • Study 1 (Children with IBS): Over an 8-week period, children who took Bacillus coagulans Unique IS-2 saw a remarkable 76.5% improvement in gas-related symptoms, with their mean score dropping from 3.4 to 0.8. The effect size was a strong 1.21. (1)
  • Study 2 (Adults with IBS): Similarly, adults experienced a 62.5% reduction in gas symptoms, with their scores decreasing from 3.2 to 1.2. The effect size here was even larger at 1.72. Both studies found these changes to be statistically significant (p < 0.0001), reinforcing the positive impact of this probiotic on gas relief. (2)

Our Criteria

The probiotics in our full database (below) are automatically ranked based on their 1) effect size for gas relief, followed by 2) effect size for overall IBS symptoms (‘Global IBS Symptoms’), and finally by 3) the quality of evidence from the studies. 

For this summary, we selected our top choices based on these rankings, along with the following additional criteria:

  • Evidence Quality Score: We only included probiotics backed by studies with an evidence quality score of 75% or higher, specifically in the context of gas/flatulence.
  • Effect Size: Only probiotics that demonstrated a moderate to high effect size (>0.5) for gas relief made the cut.
  • Clear Dosing Information: Only probiotics with clear and reliable dosing data were included.
  • Commercial Availability: Probiotics needed to be commercially available to consumers.

No Direct Comparisons 

It’s important to note that there are no direct comparisons between the probiotics in our database across identical study methods, so we can’t definitively rank one probiotic as superior to another. Bacillus coagulans Unique IS-2 shows promise for gas relief in IBS, but as with all probiotic supplements, always consult your healthcare provider before starting.

Our Ranking Probiotic Gas Relief Effect Size* Global IBS Symptoms Effect Size Evidence Quality Number of Studies Number of Participants
1 IS-2 1.43 1.45 86% 2 249

*Population values represent the per protocol population size from studies specifically assessing a gas-related parameter.

*Effect sizes are reported as the weighted mean effect size across studies.

References

  1. Sudha MR, Jayanthi N, Aasin M, et al. Efficacy of Bacillus coagulans Unique IS2 in the treatment of irritable bowel syndrome in children: a double-blind, randomised placebo-controlled study. Benef Microbes. 2018;9(4):563-572. doi:10.3920/BM2017.0129.
  2. Madempudi RS, Ahire JJ, Neelamraju J, et al. Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults. Sci Rep. 2019;9:12210. doi:10.1038/s41598-019-48554-x.
02
Results
  • Effect sizes explained

    • STRONG

      Statistically significant improvement and a Cohen’s d or h of ≥ 1.0

    • MODERATE

      Statistically significant improvement and a Cohen’s d or h of 0.5 – 1.0

    • WEAK

      Statistically significant improvement and a Cohen’s d or h of <0.5

    • NO EFFECT

      No statistically significant effect

    • NOT STUDIED

      Not studied

    • ADVERSE

      Adverse effects measured

  • Evidence quality ratings explained

  • How results are presented

03
Our Top Picks

When selecting our top probiotic picks, we ensure they are commercially available and backed by high-quality evidence, with an average score above 75% for the relevant symptom parameters. The probiotics must also demonstrate a moderate to high effect size (>0.5) for these symptoms. If there are more than five candidates, we limit our top picks to the best five based on the effect size for relevant symptoms and Global IBS symptoms, as well as evidence quality. This ensures our recommendations are practical and reliable.

Read More…

When selecting our top probiotic picks, we ensure they are commercially available and backed by high-quality evidence, with an average score above 75% for the relevant symptom parameters. The probiotics must also demonstrate a moderate to high effect size (>0.5) for these symptoms. If there are more than five candidates, we limit our top picks to the best five based on the effect size for relevant symptoms and Global IBS symptoms, as well as evidence quality. This ensures our recommendations are practical and reliable.

Read More…

When selecting our top probiotic picks, we ensure they are commercially available and backed by high-quality evidence, with an average score above 75% for the relevant symptom parameters. The probiotics must also demonstrate a moderate to high effect size (>0.5) for these symptoms. If there are more than five candidates, we limit our top picks to the best five based on the effect size for relevant symptoms and Global IBS symptoms, as well as evidence quality. This ensures our recommendations are practical and reliable.

Be the first to know.

Get notified about the latest clinical study results across 40+ probiotic strains studied in IBS populations

Form Submit